{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:17:39Z","timestamp":1778685459817,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["C2019-1051-09"],"award-info":[{"award-number":["C2019-1051-09"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010097","name":"China Association for Science and Technology","doi-asserted-by":"publisher","award":["ZZ20004"],"award-info":[{"award-number":["ZZ20004"]}],"id":[{"id":"10.13039\/100010097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7191009"],"award-info":[{"award-number":["7191009"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7204293"],"award-info":[{"award-number":["7204293"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872160"],"award-info":[{"award-number":["81872160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072940"],"award-info":[{"award-number":["82072940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["3332019053"],"award-info":[{"award-number":["3332019053"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020AAA0105004"],"award-info":[{"award-number":["2020AAA0105004"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020AAA0105000"],"award-info":[{"award-number":["2020AAA0105000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.canlet.2021.01.016","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T03:19:22Z","timestamp":1611285562000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Factors associated with chemotherapy benefit in breast cancer patients with midrange Oncotype DX breast recurrence scores"],"prefix":"10.1016","volume":"503","author":[{"given":"Ran","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-0344","authenticated-orcid":false,"given":"Liqiang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2021.01.016_bib1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2021.01.016_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000443159","article-title":"Breast cancer is our global responsibility","volume":"10","author":"Harbeck","year":"2015","journal-title":"Breast Care"},{"key":"10.1016\/j.canlet.2021.01.016_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7314\/APJCP.2016.17.S3.43","article-title":"Incidence and mortality and Epidemiology of breast cancer in the world","volume":"17","author":"Ghoncheh","year":"2016","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.canlet.2021.01.016_bib4","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1002\/cam4.943","article-title":"Progress in the clinical detection of heterogeneity in breast cancer","volume":"5","author":"Song","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.canlet.2021.01.016_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/a-0897-6457","article-title":"Primary therapy of early breast cancer: evidence, controversies, consensus: spectrum of opinion of German specialists on the 16th st. Gallen international breast cancer conference (vienna 2019)","volume":"79","author":"Untch","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.canlet.2021.01.016_bib6","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","article-title":"Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer","volume":"24","author":"Paik","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.01.016_bib7","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.01.016_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41523-018-0090-6","article-title":"21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer","volume":"4","author":"Geyer","year":"2018","journal-title":"NPJ Breast Cancer"},{"issue":"Suppl 3","key":"10.1016\/j.canlet.2021.01.016_bib9","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S0960-9776(09)70290-5","article-title":"Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays","volume":"18","author":"Albain","year":"2009","journal-title":"Breast"},{"key":"10.1016\/j.canlet.2021.01.016_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/modpathol.2013.36","article-title":"Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis","volume":"26","author":"Klein","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2021.01.016_bib11","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","article-title":"Prospective validation of a 21-gene expression assay in breast cancer","volume":"373","author":"Sparano","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.01.016_bib12","article-title":"Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: a secondary analysis of the TAILORx randomized clinical trial","author":"Sparano","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canlet.2021.01.016_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.01.016_bib14","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1904819","article-title":"Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer","volume":"380","author":"Sparano","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.01.016_bib15","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1200\/JCO.2011.35.3714","article-title":"Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors","volume":"29","author":"Tang","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.01.016_bib16","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2007.14.4501","article-title":"Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features","volume":"26","author":"Goldstein","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.01.016_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10549-018-05088-6","article-title":"Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer","volume":"176","author":"Mutonga","year":"2019","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.canlet.2021.01.016_bib18","first-page":"184","article-title":"Risk factors and histopathological features of breast cancer among women with different menopausal status and age at diagnosis","volume":"22","author":"Unlu","year":"2017","journal-title":"J BUON"},{"key":"10.1016\/j.canlet.2021.01.016_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/CPath.S31563","article-title":"Diversity of breast carcinoma: histological subtypes and clinical relevance","volume":"8","author":"Makki","year":"2015","journal-title":"Clin. Med. Insights Pathol."},{"key":"10.1016\/j.canlet.2021.01.016_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.2007.15.1068","article-title":"Development of the 21-gene assay and its application in clinical practice and clinical trials","volume":"26","author":"Sparano","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.01.016_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/IJWH.S124520","article-title":"Spotlight on the utility of the Oncotype DX((R)) breast cancer assay","volume":"10","author":"Siow","year":"2018","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.canlet.2021.01.016_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1200\/JCO.18.01412","article-title":"Estimating risk of recurrence for early breast cancer: integrating clinical and genomic risk","volume":"37","author":"Dowsett","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.01.016_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-010-1331-z","article-title":"Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20","volume":"127","author":"Tang","year":"2011","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.canlet.2021.01.016_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ypmed.2016.05.017","article-title":"The influence of marital status on the use of breast, cervical, and colorectal cancer screening","volume":"89","author":"Hanske","year":"2016","journal-title":"Prev. Med."},{"key":"10.1016\/j.canlet.2021.01.016_bib25","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/cncr.29171","article-title":"Marital status and head and neck cancer outcomes","volume":"121","author":"Inverso","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2021.01.016_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/COC.0000000000000530","article-title":"Effects of social and contextual factors including marital status and children on the use of palliative chemotherapy in metastatic colorectal cancer","volume":"42","author":"Ahmed","year":"2019","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.01.016_bib27","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/PAS.0000000000000749","article-title":"The surveillance, Epidemiology, and End results (SEER) Program and pathology: toward strengthening the critical relationship","volume":"40","author":"Duggan","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2021.01.016_bib28","first-page":"216","article-title":"Limitations and biases of the surveillance, Epidemiology, and End results database","volume":"36","author":"Park","year":"2012","journal-title":"Curr. Probl. Canc."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352100032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352100032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:52:54Z","timestamp":1778683974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352100032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":28,"alternative-id":["S030438352100032X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.01.016","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with chemotherapy benefit in breast cancer patients with midrange Oncotype DX breast recurrence scores","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}